UK CF Registry. UK Cystic Fibrosis Registry Annual Data Report 2020. 2020. https://www.cysticfibrosis.org.uk/the-work-we-do/uk-cf-registry/reporting-and-resources. Accessed on 20th Feb 2022.
Google Scholar
Clinical and Functional Translation of CFTR; 2022. https://cftr2.org/. Accessed 3 Mar 2022.
Ranganathan SC, Skoric B, Ramsay KA, Carzino R, Gibson AM, Hart E, Harrison J, Bell SC, Kidd TJ. Australian Respiratory Early Surveillance Team for Cystic Fibrosis: Geographical differences in first acquisition of Pseudomonas aeruginosa in cystic fibrosis. Ann Am Thorac Soc. 2013;10(2):108–14.
Article
Google Scholar
Gilligan PH. Infections in patients with cystic fibrosis: diagnostic microbiology update. Clin Lab Med. 2014;34(2):197–217.
Article
Google Scholar
Chiappini E, Taccetti G, de Martino M. Bacterial lung infections in cystic fibrosis patients: an update. Pediatr Infect Dis J. 2014;33(6):653–4.
Article
Google Scholar
Burgel PR, Paugam A, Hubert D, Martin C. Aspergillus fumigatus in the cystic fibrosis lung: pros and cons of azole therapy. Infect Drug Resist. 2016;9:229–38.
Article
CAS
Google Scholar
Saunders RV, Modha DE, Claydon A, Gaillard EA. Chronic Aspergillus fumigatus colonization of the pediatric cystic fibrosis airway is common and may be associated with a more rapid decline in lung function. Med Mycol. 2016;54(5):537–43.
Article
Google Scholar
Mendell MJ, Mirer AG, Cheung K, Tong M, Douwes J. Respiratory and allergic health effects of dampness, mold, and dampness-related agents: a review of the epidemiologic evidence. Environ Health Perspect. 2011;119(6):748–56.
Article
CAS
Google Scholar
Crawford JA, Rosenbaum PF, Anagnost SE, Hunt A, Abraham JL. Indicators of airborne fungal concentrations in urban homes: understanding the conditions that affect indoor fungal exposures. Sci Total Environ. 2015;517:113–24.
Article
CAS
Google Scholar
Robertson S, Douglas P, Jarvis D, Marczylo E. Bioaerosol exposure from composting facilities and health outcomes in workers and in the community: A systematic review update. Int J Hyg Environ Health. 2019;222(3):364–86.
Article
CAS
Google Scholar
Douwes J, Thorne P, Pearce N, Heederik D. Bioaerosol health effects and exposure assessment: progress and prospects. Ann Occup Hyg. 2003;47(3):187–200.
CAS
Google Scholar
Douglas P, Fecht D, Jarvis D. Characterising populations living close to intensive farming and composting facilities in England. Front Environ Sci Eng. 2021;15(3):40.
Article
Google Scholar
Taha MPM, Drew GH, Longhurst PJ, Smith R, Pollard SJT. Bioaerosol releases from compost facilities: Evaluating passive and active source terms at a green waste facility for improved risk assessments. Atmos Environ. 2006;40(6):1159–69.
Article
CAS
Google Scholar
Environment Agency and Department for Environment, Food & Rural Affairs. Risk assessments for your environmental permit; 2016. https://www.gov.uk/guidance/risk-assessments-for-your-environmental-permit. Accessed 3 Mar 2022.
Williams B, Douglas P, Roca Barcelo A, Hansell AL, Hayes E. Estimating Aspergillus fumigatus exposure from outdoor composting activities in England between 2005 and 14. Waste Manage. 2019;84:235–44.
Article
CAS
Google Scholar
Mack SM, Madl AK, Pinkerton KE. Respiratory Health Effects of Exposure to Ambient Particulate Matter and Bioaerosols. Compr Physiol. 2019;10(1):1–20.
Google Scholar
Douglas P, Bakolis I, Fecht D, Pearson C, Leal Sanchez M, Kinnersley R, de Hoogh K, Hansell AL. Respiratory hospital admission risk near large composting facilities. Int J Hyg Environ Health. 2016;219(4–5):372–9.
Article
Google Scholar
Roca-Barcelo A, Douglas P, Fecht D, Sterrantino AF, Williams B, Blangiardo M, Gulliver J, Hayes ET, Hansell AL. Risk of respiratory hospital admission associated with modelled concentrations of Aspergillus fumigatus from composting facilities in England. Environ Res. 2020;183:108949.
Article
CAS
Google Scholar
Walser SM, Gerstner DG, Brenner B, Bünger J, Eikmann T, Janssen B, Kolb S, Kolk A, Nowak D, Raulf M, et al. Evaluation of exposure–response relationships for health effects of microbial bioaerosols – A systematic review. Int J Hyg Environ Health. 2015;218(7):577–89.
Article
Google Scholar
Taylor-Robinson D, Archangelidi O, Carr SB, Cosgriff R, Gunn E, Keogh RH, MacDougall A, Newsome S, Schlüter DK, Stanojevic S, et al. Data Resource Profile: The UK Cystic Fibrosis Registry. Int J Epidemiol. 2018;47(1):9–10e.
Article
Google Scholar
ONS. Office for National Statistics; Postcode Headcounts and Household Estimates - 2011 Census. 2013. https://www.nomisweb.co.uk/census/2011/postcode_headcounts_and_household_estimates. Accessed 22 Feb 2022.
Google Scholar
Ordnance Survey. Ordnance Survey. 2022. https://www.ordnancesurvey.co.uk/business-and-government/products/code-point-open.html. Accessed 08 March 2022.
Google Scholar
Szczesniak R, Heltshe SL, Stanojevic S, Mayer-Hamblett N. Use of FEV1 in cystic fibrosis epidemiologic studies and clinical trials: A statistical perspective for the clinical researcher. J Cyst Fibros. 2017;16(3):318–26.
Article
Google Scholar
Quanjer PH, Stanojevic S, Cole TJ, Baur X, Hall GL, Culver BH, Enright PL, Hankinson JL, Ip MS, Zheng J, et al. Multi-ethnic reference values for spirometry for the 3–95-yr age range: the global lung function 2012 equations. Eur Respir J. 2012;40(6):1324–43.
Article
Google Scholar
Hoo ZH, Campbell MJ, Curley R, Walters SJ, Wildman MJ. Do cystic fibrosis centres with the lowest FEV1 still use the least amount of intravenous antibiotics? A registry-based comparison of intravenous antibiotic use among adult CF centres in the UK. J Cyst Fibros. 2018;17(3):360–7.
Article
Google Scholar
Kerem E, Viviani L, Zolin A, MacNeill S, Hatziagorou E, Ellemunter H, Drevinek P, Gulmans V, Krivec U, Olesen H. Factors associated with FEV<sub>1</sub> decline in cystic fibrosis: analysis of the ECFS Patient Registry. Eur Respir J. 2014;43(1):125.
Article
Google Scholar
Stevens DA, Moss RB, Kurup VP, Knutsen AP, Greenberger P, Judson MA, Denning DW, Crameri R, Brody AS, Light M, et al. Allergic bronchopulmonary aspergillosis in cystic fibrosis–state of the art: Cystic Fibrosis Foundation Consensus Conference. Clin Infect Dis. 2003;37(Suppl 3):S225-264.
Article
Google Scholar
Environment Agency. Waste exemption: T23 aerobic composting and associated prior treatment; 2014. https://www.gov.uk/guidance/waste-exemption-t23-aerobic-composting-and-associated-prior-treatment. Accessed 3 Mar 2022.
Williams B, Douglas P, Roca Barcelo A, Hansell AL, Hayes E. Estimating Aspergillus fumigatus exposure from outdoor composting activities in England between 2005 and 14. Waste Manag. 2019;84:235–44.
Article
CAS
Google Scholar
Pearson C, Littlewood E, Douglas P, Robertson S, Gant TW, Hansell AL. Exposures and health outcomes in relation to bioaerosol emissions from composting facilities: a systematic review of occupational and community studies. J Toxicol Environ Health B Crit Rev. 2015;18(1):43–69.
Article
CAS
Google Scholar
Vaz Fragoso CA, McAvay G, Van Ness PH, Metter EJ, Ferrucci L, Yaggi HK, Concato J, Gill TM. Aging-Related Considerations When Evaluating the Forced Expiratory Volume in 1 Second (FEV1) Over Time. J Gerontol A Biol Sci Med Sci. 2016;71(7):929–34.
Article
Google Scholar
Lalley PM. The aging respiratory system—Pulmonary structure, function and neural control. Respir Physiol Neurobiol. 2013;187(3):199–210.
Article
Google Scholar
Vogel M. Vogel M. Childsds R package version 0.8.0 2022: data and methods around reference values in pediatrics; 2022. https://cran.r-project.org/web/packages/childsds/index.html. Accessed 10 Mar 2022.
Goss CH, Sykes J, Stanojevic S, Marshall B, Petren K, Ostrenga J, Fink A, Elbert A, Quon BS, Stephenson AL. Comparison of Nutrition and Lung Function Outcomes in Patients with Cystic Fibrosis Living in Canada and the United States. Am J Respir Crit Care Med. 2018;197(6):768–75.
Article
Google Scholar
Stenbit AE, Flume PA. Pulmonary exacerbations in cystic fibrosis. 2011;17(6):442–7.
Google Scholar
Office for National Statistics (ONS). 2011 Census: aggregate data. [data collection]: UK Data Service; SN: 7427. https://doi.org/10.5257/census/aggregate-2011-2. Accessed 3 Mar 2022.
Taylor-Robinson DC, Smyth RL, Diggle PJ, Whitehead M. The effect of social deprivation on clinical outcomes and the use of treatments in the UK cystic fibrosis population: a longitudinal study. Lancet Respir Med. 2013;1(2):121–8.
Article
Google Scholar
De Boeck K, Amaral MD. Progress in therapies for cystic fibrosis. Lancet Respir Med. 2016;4(8):662–74.
Article
Google Scholar
Middleton PG, Mall MA, Dřevínek P, Lands LC, McKone EF, Polineni D, Ramsey BW, Taylor-Cousar JL, Tullis E, Vermeulen F, et al. Elexacaftor–Tezacaftor–Ivacaftor for Cystic Fibrosis with a Single Phe508del Allele. N Engl J Med. 2019;381(19):1809–19.
Article
CAS
Google Scholar
Heijerman HGM, McKone EF, Downey DG, Van Braeckel E, Rowe SM, Tullis E, Mall MA, Welter JJ, Ramsey BW, McKee CM, et al. Efficacy and safety of the elexacaftor plus tezacaftor plus ivacaftor combination regimen in people with cystic fibrosis homozygous for the <em>F508del</em> mutation: a double-blind, randomised, phase 3 trial. The Lancet. 2019;394(10212):1940–8.
Article
CAS
Google Scholar
R Core Team. R: A language and environment for statistical computing. Vienna: R Foundation for Statistical Computing; 2022. https://www.R-project.org/.
Google Scholar
Burnham KP, Anderson DR. Model Selection and Multimodel Inference: A Practical Information-Theoretic Approach. New York: Springer; 2003.
Google Scholar
Herr CEW, Zur Nieden A, Jankofsky M, Stilianakis NI, Boedeker RH, Eikmann TF. Effects of bioaerosol polluted outdoor air on airways of residents: a cross sectional study. Occup Environ Med. 2003;60(5):336–42.
Article
CAS
Google Scholar
Aatamila M, Verkasalo PK, Korhonen MJ, Suominen AL, Hirvonen M-R, Viluksela MK, Nevalainen A. Odour annoyance and physical symptoms among residents living near waste treatment centres. Environ Res. 2011;111(1):164–70.
Article
CAS
Google Scholar
Senthilselvan A, Chénard L, Grover V, Kirychuk SP, Hagel L, Ulmer K, Hurst TS, Dosman JA. Excess longitudinal decline in lung function in grain farmers. J Agromedicine. 2010;15(2):157–65.
Article
Google Scholar
Jacobsen G, Schlünssen V, Schaumburg I, Taudorf E, Sigsgaard T. Longitudinal lung function decline and wood dust exposure in the furniture industry. Eur Respir J. 2008;31(2):334.
Article
CAS
Google Scholar
Wainwright CE, Elborn JS, Ramsey BW, Marigowda G, Huang X, Cipolli M, Colombo C, Davies JC, De Boeck K, Flume PA, et al. Lumacaftor-Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del CFTR. N Engl J Med. 2015;373(3):220–31.
Article
CAS
Google Scholar
Ramsey BW, Davies J, McElvaney NG, Tullis E, Bell SC, Dřevínek P, Griese M, McKone EF, Wainwright CE, Konstan MW, et al. A CFTR Potentiator in Patients with Cystic Fibrosis and the G551D Mutation. N Engl J Med. 2011;365(18):1663–72.
Article
CAS
Google Scholar
Cuthbertson L, Felton I, James P, Cox MJ, Bilton D, Schelenz S, Loebinger MR, Cookson WOC, Simmonds NJ, Moffatt MF. The fungal airway microbiome in cystic fibrosis and non-cystic fibrosis bronchiectasis. J Cyst Fibros. 2021;20(2):295–302.
Article
CAS
Google Scholar
Burgel P-R, Paugam A, Hubert D, Martin C. Aspergillus fumigatus in the cystic fibrosis lung: pros and cons of azole therapy. Infection and drug resistance. 2016;9:229–38.
Article
CAS
Google Scholar
Kraemer R, Baldwin DN, Ammann RA, Frey U, Gallati S. Progression of pulmonary hyperinflation and trapped gas associated with genetic and environmental factors in children with cystic fibrosis. Respir Res. 2006;7(1):138.
Article
Google Scholar
Pankhurst LJ, Deacon LJ, Liu J, Drew GH, Hayes ET, Jackson S, Longhurst PJ, Longhurst JWS, Pollard SJT, Tyrrel SF. Spatial variations in airborne microorganism and endotoxin concentrations at green waste composting facilities. Int J Hyg Environ Health. 2011;214(5):376–83.
Article
CAS
Google Scholar
Deacon L, Pankhurst L, Liu J, Drew GH, Hayes ET, Jackson S, Longhurst J, Longhurst P, Pollard S, Tyrrel S. Endotoxin emissions from commercial composting activities. Environ Health. 2009;8(1):S9.
Article
Google Scholar